Infection with parapoxvirus induces CD30-positive cutaneous infiltrates in humans

被引：28
|
作者：
Rose, C
Starostik, P
Bröcker, EB
机构：
[1] Univ Wurzburg, Dept Dermatol, D-97080 Wurzburg, Germany
[2] Univ Wurzburg, Dept Pathol, D-97080 Wurzburg, Germany
来源：
JOURNAL OF CUTANEOUS PATHOLOGY | 1999年 / 26卷 / 10期
关键词：
D O I：
10.1111/j.1600-0560.1999.tb01800.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Expression of CD30 is a distinct feature of B- or T-cell activation, found in Hodgkin's disease, large cell anaplastic lymphoma, lymphomatoid papulosis, as well as in certain viral infections such as human T-lymphotropic virus type I, HIV, hepatitis B and C virus, and Epstein-Barr virus. Here, we report highly proliferative CD30-positive cutaneous infiltrates in 3 patients with Milkers's nodules, adding para-poxvirus infection to the spectrum of CD30-positive benign lymphoproliferations.
引用
收藏
页码：520 / 522
页数：3
相关论文
共 50 条
  • [21] CD30-positive cutaneous lymphoma: report of four cases with an emphasis on clinicopathological correlations
    de Sousa Vargas, Thiago Jeunon
    Jorge, Samira Barroso
    de Mello Gonzaga, Yung Bruno
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2017, 92 (01) : 86 - 91
  • [22] CD30-positive cutaneous T-cell lymphoma with concurrent solid tumour
    Au, WY
    Yeung, CK
    Chan, HH
    Wong, RWM
    Shek, TW
    BRITISH JOURNAL OF DERMATOLOGY, 2002, 146 (06) : 1091 - 1095
  • [23] CD30-positive primary cutaneous lymphoproliferative disorders: molecular alterations and targeted therapies
    Prieto-Torres, Lucia
    Rodriguez-Pinilla, Socorro M.
    Onaindia, Arantza
    Ara, Mariano
    Requena, Luis
    Piris, Miguel A.
    HAEMATOLOGICA, 2019, 104 (02) : 226 - 235
  • [24] Loss of expression of 5-hydroxymethylcytosine in CD30-positive cutaneous lymphoproliferative disorders
    De Souza, Aieska
    Tinguely, Marianne
    Pfaltz, Madeleine
    Burghart, Daniel R.
    Kempf, Werner
    JOURNAL OF CUTANEOUS PATHOLOGY, 2014, 41 (12) : 901 - 906
  • [25] Adcetris® approved for the Treatment of CD30-positive cutaneous T-Cell-Lymphoma
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 (05) : 336 - 336
  • [26] Expression of MUM1 in primary cutaneous CD30-positive lymphoproliferative disorders
    Wasco, M.
    Ma, L.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2007, 34 (01) : 94 - 94
  • [27] Genetic alterations in CD30-positive lymphoproliferations
    Maurus, K.
    Roth, S.
    Appenzeller, S.
    Goebeler, M.
    Rosenwald, A.
    Geissinger, E.
    Wobser, M.
    EUROPEAN JOURNAL OF CANCER, 2019, 119 : S14 - S15
  • [28] Pityriasis lichenoides with CD30-positive lymphocytes
    Cernik, Christina
    Kadin, Marshall
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) : AB139 - AB139
  • [29] Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders
    Sciallis, Andrew P.
    Law, Mark E.
    Inwards, David J.
    McClure, Rebecca F.
    Macon, William R.
    Kurtin, Paul J.
    Dogan, Ahmet
    Feldman, Andrew L.
    MODERN PATHOLOGY, 2012, 25 (07) : 983 - 992
  • [30] Brentuximab vedotin for CD30-positive tumours
    Masuda, Shigeo
    Miyagawa, Shigeru
    Nakamura, Terumi
    Khurram, Maaz Asher
    Sawa, Yoshiki
    LANCET ONCOLOGY, 2016, 17 (09): : E371 - E371
12345